Pages that link to "Q33849248"
Jump to navigation
Jump to search
The following pages link to Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy (Q33849248):
Displaying 50 items.
- Tumor progression, metastasis, and modulators of epithelial-mesenchymal transition in endometrioid endometrial carcinoma: an update (Q26779980) (← links)
- Targeting LKB1 in cancer - exposing and exploiting vulnerabilities (Q26801412) (← links)
- Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives (Q28071388) (← links)
- ARID1A Is Essential for Endometrial Function during Early Pregnancy (Q30370823) (← links)
- Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy (Q33422258) (← links)
- Lactoferrin-iCre: a new mouse line to study uterine epithelial gene function (Q33765518) (← links)
- Conditional deletion of Sox17 reveals complex effects on uterine adenogenesis and function (Q33923057) (← links)
- An AMPK-independent signaling pathway downstream of the LKB1 tumor suppressor controls Snail1 and metastatic potential (Q34117181) (← links)
- Cooperation between p53 and the telomere-protecting shelterin component Pot1a in endometrial carcinogenesis. (Q34300546) (← links)
- Physiological and molecular determinants of embryo implantation (Q34320970) (← links)
- Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model (Q34323399) (← links)
- Recent progress on liver kinase B1 (LKB1): expression, regulation, downstream signaling and cancer suppressive function (Q34358845) (← links)
- Stromal liver kinase B1 [STK11] signaling loss induces oviductal adenomas and endometrial cancer by activating mammalian Target of Rapamycin Complex 1. (Q34390606) (← links)
- Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53. (Q34458796) (← links)
- Liver kinase B1 (LKB1) in the pathogenesis of epithelial cancers (Q34899298) (← links)
- The LKB1 tumor suppressor as a biomarker in mouse and human tissues (Q35004753) (← links)
- Cell-specific conditional deletion of Pten in the uterus results in differential phenotypes (Q35113273) (← links)
- The regulation of embryo implantation and endometrial decidualization by progesterone receptor signaling (Q35667152) (← links)
- Is 5´-AMP-Activated Protein Kinase Both Jekyll and Hyde in Bladder Cancer? (Q35813290) (← links)
- A new hypothesis for the cancer mechanism (Q35954093) (← links)
- Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo (Q36032452) (← links)
- LKB1 gene inactivation does not sensitize non-small cell lung cancer cells to mTOR inhibitors in vitro (Q36034229) (← links)
- LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment (Q36266500) (← links)
- Conditional deletion of Tsc1 in the female reproductive tract impedes normal oviductal and uterine function by enhancing mTORC1 signaling in mice (Q36950142) (← links)
- Symposium on advances in endometrial cancer epidemiology and biology. (Q37011786) (← links)
- Somatic PIK3CA mutations as a driver of sporadic venous malformations. (Q37130685) (← links)
- Impact of genetic alterations on mTOR-targeted cancer therapy (Q37353954) (← links)
- Dysregulation of mTOR activity through LKB1 inactivation (Q37354026) (← links)
- Targeting the LKB1 tumor suppressor (Q37506032) (← links)
- The small GTPase Rheb is required for spermatogenesis but not oogenesis (Q37695416) (← links)
- A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibition (Q37695840) (← links)
- Germinal center kinases in immune regulation. (Q37727837) (← links)
- A phase I study of temsirolimus and thoracic radiation in non--small-cell lung cancer (Q37728090) (← links)
- Molecular mechanisms of tumor suppression by LKB1. (Q37824725) (← links)
- LKB1 in lung cancerigenesis: a serine/threonine kinase as tumor suppressor (Q37850361) (← links)
- The tumor suppressor kinase LKB1: lessons from mouse models (Q37934215) (← links)
- Unravelling the connection between metabolism and tumorigenesis through studies of the liver kinase B1 tumour suppressor (Q38148147) (← links)
- The double-edged sword of AMPK signaling in cancer and its therapeutic implications (Q38313164) (← links)
- LKB1 as a Tumor Suppressor in Uterine Cancer: Mouse Models and Translational Studies (Q39026772) (← links)
- LKB1-AMPK axis revisited (Q39313566) (← links)
- Loss of LKB1 and p53 synergizes to alter fallopian tube epithelial phenotype and high-grade serous tumorigenesis. (Q41179162) (← links)
- MIG-6 negatively regulates STAT3 phosphorylation in uterine epithelial cells (Q47634931) (← links)
- Tissue-Specific Ablation of the LIF Receptor in the Murine Uterine Epithelium Results in Implantation Failure (Q50447160) (← links)
- Clonality analysis suggests that STK11 gene mutations are involved in progression of lobular endocervical glandular hyperplasia (LEGH) to minimal deviation adenocarcinoma (MDA). (Q51018456) (← links)
- Axons hooked to Schwann cell metabolism. (Q54319719) (← links)
- Oncogenic events associated with endometrial and ovarian cancers are rare in endometriosis. (Q54361550) (← links)
- MIG-6 suppresses endometrial epithelial cell proliferation by inhibiting phospho-AKT. (Q54968730) (← links)
- Modeling Endometrial Cancer: Past, Present, and Future (Q57170070) (← links)
- SOX17 regulates uterine epithelial-stromal cross-talk acting via a distal enhancer upstream of Ihh (Q57793556) (← links)
- The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten (Q58704993) (← links)